secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyell Immunopharma, Inc. (LYEL)
CIK:        0001806952
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001193125-25-012249
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyell Immunopharma receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------------------

- Notice received Jan 23, 2025: common stock bid price below $1.00 for 33 consecutive business days.
- Company has 180 calendar days, until July 22, 2025, to regain compliance by closing at $1.00 for 10 consecutive days.
- If not compliant by July 22, may qualify for an additional 180-day period by transferring to Nasdaq Capital Market.
- Company will evaluate options, including a reverse stock split, to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1806952/000119312525012249/0001193125-25-012249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1806952/000119312525012249/d884359d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-012249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer